1203486-58-1 Usage
Description
Methyl 3-amino-5-morpholino-2-nitrobenzoate is a chemical compound with the molecular formula C11H13N3O5. It is a versatile intermediate commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. Known for its nitro group, it is useful in the development of nitroaromatic derivatives and has potential applications in the treatment of certain diseases, as well as in the field of medicinal chemistry.
Uses
Used in Pharmaceutical Industry:
Methyl 3-amino-5-morpholino-2-nitrobenzoate is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its presence in the molecule allows for the development of nitroaromatic derivatives, which can be further modified to produce a wide range of valuable compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, Methyl 3-amino-5-morpholino-2-nitrobenzoate is used as a building block for the synthesis of various agrochemicals. Its versatility and reactivity make it a valuable component in the development of new and effective products for agricultural use.
Used in Medicinal Chemistry:
Methyl 3-amino-5-morpholino-2-nitrobenzoate is used as a versatile intermediate in various organic reactions in the field of medicinal chemistry. Its unique structure and functional groups enable the synthesis of a broad range of compounds with potential applications in the treatment of various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1203486-58-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,3,4,8 and 6 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1203486-58:
(9*1)+(8*2)+(7*0)+(6*3)+(5*4)+(4*8)+(3*6)+(2*5)+(1*8)=131
131 % 10 = 1
So 1203486-58-1 is a valid CAS Registry Number.
1203486-58-1Relevant articles and documents
BENZIMIDAZOLE DERIVATIVES AS PI3 KINASE INHIBITORS
-
, (2012/04/18)
This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ OH kinase family (hereinafter PI3 kinases), suitably, PI3Kα, PI3Kβ, PI3Kβ, and/or PI3Kγ. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3Kβ selective benzimidazoles compounds for treating cancer.
